Execution Underwriting for PE-Backed Companies

Execution Underwriting for PE-Backed Companies | Forged Horizons Advisors

Forged Horizons Advisors | Precision Exits™ Book Diagnostic

Your exit multiple is set during execution, not at sale.

QoE verifies the numbers. Execution Underwriting tests whether the investment thesis, operating plan, required investments, and buyer-grade proof hold together before diligence does.

Buyers find gaps before the board does.

The board hears progress. Buyers test proof, sequencing, investment needs, leadership capacity, and the post-exit roadmap.

Clarity now. Fewer surprises later.

The diagnostic identifies where one company may already be behind the thesis, but not yet behind the dashboard.

Book a 20-Minute Execution Underwriting Diagnostic

Problem

The dashboard can stay green while the thesis falls behind.

Execution drift rarely begins as obvious failure. It starts when the investment thesis, management assumptions, and operating reality stop compounding in the same direction.

The company looks busy. The dashboard looks acceptable. The board hears progress. But the proof buyers will eventually diligence is not strengthening at the same pace as the story.

The board hears progress. Why does the buyer see something different?

Boards see the dashboard. Buyers test the proof behind it: ownership assignments, sequencing decisions, required investment commitments, and the credibility of the post-exit roadmap. Those are different questions from the same data.

Boardroom scene

Three reasonable answers can still create one fragile plan.

CFO

Margin expansion depends on utilization and add-back discipline.

COO

Margin expansion depends on delivery standardization and capacity planning.

CRO

Growth depends on enterprise customization and faster sales response.

Each answer can be reasonable. The issue is whether those answers add up to one executable plan before a buyer tests the same gap in diligence.

Trust line

This is not a management audit.

It is a pressure test of whether sponsor expectations, management assumptions, and buyer proof requirements are operating from the same plan.

Consequence

A gap found 18 months before exit is a fixable operating issue. A gap found in diligence is a valuation issue.

Private equity has a catch-up mechanism for carry. Most portfolio companies do not have one for execution drift. When the dashboard stays green but the thesis falls behind, value starts to leak before the board names the issue.

Gap found 18 months before exit

Fixable operating issue.

Correction window exists. Ownership, sequencing, and proof requirements can be reset before buyers test them.

Gap found once the buyer has leverage

Valuation issue.

Illustrative: 0.5 to 1.5 turns of exit value already at risk. The correction window is closed.

Return of Confidence

Management understands the investment thesis, timeline, and top value creation priorities.

Preferred Execution Return

The first 100 to 180 days translate the thesis into owners, cadence, metrics, and decisions.

Execution Catch-Up

If drift appears, leadership needs a focused correction window before delays compound into trapped EBITDA, missed milestones, or credibility loss.

Buyer-Grade Proof

By exit, the story must be supported by evidence buyers can diligence: growth quality, margin durability, leadership depth, and operating discipline.

Hidden risk

Most value creation plans fail less from one bad initiative than from Absorption Risk.

Absorption Risk appears when too many simultaneous initiatives compete for the same leadership bandwidth, data, process maturity, systems, and decision capacity.

The underwriting question is whether the plan includes the OpEx, CapEx, talent, systems, sequencing, and change capacity required to absorb the work.

Illustrative cost

Late gaps narrow buyer conviction.

When execution gaps surface late, the cost can show up as lower confidence in the premium story, a weaker post-exit roadmap, more buyer diligence, or a lower valuation range.

0.5 to 1.5 turns

If Absorption Risk is invisible on the dashboard, how does the board see it?

It rarely shows up as a single failed initiative. It shows up as slower-than-expected proof accumulation, initiative sequencing that keeps shifting, and a management team that can describe the strategy but not the ownership structure behind it.

Signals

Signals you may already be behind the thesis, but not yet behind the dashboard.

“The dashboard looks fine, but I’m not sure the proof is compounding.”

The story and the evidence are moving at different speeds. Buyers will find the gap between them before the board does.

“We have too many things in flight at once.”

Absorption Risk. Too many simultaneous initiatives competing for the same leadership bandwidth, data, process maturity, and decision capacity.

“The board, deal team, and management each describe progress differently.”

Three versions of progress means the plan has not been translated into one set of owners, cadence, and tradeoffs. Buyers will surface this gap in management interviews.

“The exit narrative is strong, but I’m not sure the operations can support it yet.”

The story is ahead of the evidence. Execution Underwriting tests whether the proof base can carry the premium the narrative is asking buyers to pay.

“The required investments are in the plan, but I’m not sure they’re fully underwritten.”

Implied investments without formal underwriting create the valuation surprises buyers find in diligence and lenders find in covenant reviews.

“Management can describe the strategy, but not who owns what, at what cadence.”

Strategy without ownership is a slide deck, not an operating plan. Buyers test the operating plan. The slide deck does not survive that test.

Intervention

Execution Underwriting is the operating companion to QoE.

Precision Exits™ helps sponsors preserve and expand exit value through Execution Underwriting. It does that by surfacing where the operating plan, management assumptions, required investments, and buyer proof requirements are no longer aligned.

Execution Underwriting is a bounded operator diagnostic on the specific asset in front of you. It tests whether the management team, operating cadence, ownership model, and proof base can carry the future earnings bridge buyers are being asked to pay for.

QoE validates historical earnings. What validates whether the future earnings bridge is executable?

QoE answers: did the company earn what it claimed? Execution Underwriting answers: can management deliver what buyers are being asked to pay for? Those are different questions. Both matter before close and before exit.

Primary method

Strategic Table Read™

Align leadership to the investment thesis. Translate the plan into operating choices, owners, tradeoffs, and required investments.
Build execution cadence. Move work, decisions, and accountability at the pace value creation requires.
Focus on the few moves that create value. Prioritize the initiatives that support EBITDA, cash, and exit readiness.
Underwrite proof, process, and required investments. Confirm the OpEx, CapEx, data, systems, and processes buyers, lenders, and boards will trust.
Prepare leadership for ownership demands. Test whether capacity, incentives, decision rights, and talent gaps match what the investment requires.

When sponsors use this

Sponsors use Execution Underwriting when the company is not obviously broken, but the value bridge has not been pressure-tested.

Situation	What is happening	What FHA tests
Pre-close	The investment thesis looks attractive, but required investments, sequencing, talent gaps, and execution probabilities are not fully underwritten.	Whether management can run the thesis under sponsor cadence.
First board or value creation reset	The plan exists, but management is not operating from one version of it.	Whether ownership, cadence, and tradeoffs are aligned.
Mid-hold drift	The dashboard is acceptable, but the thesis is not compounding cleanly.	Whether execution assumptions still hold.
12 to 24 months pre-exit	The company is busy, but buyer-grade proof and the post-exit roadmap are not strong enough to support the premium.	Whether the story can survive diligence.

Diagnostic output

The 20-minute diagnostic gives the sponsor one concrete read, not a sales pitch.

One company where the thesis may be ahead of operating proof.

The gap most likely to surface in board, lender, or buyer scrutiny.

A first view of the hidden Absorption Risk in the current plan.

A recommendation on whether a deeper Execution Underwriting diagnostic is worth your time.

Who benefits

The same diagnostic helps each stakeholder protect value from a different angle.

Independent Sponsors

Validate execution risk, required investments, and management readiness before close. Protect the thesis before capital is committed.

Operating Partners

Convert the plan into buyer-grade proof and a credible post-exit roadmap. Reduce diligence exposure before the process begins.

Deal Teams

Stronger evidence now. Stronger negotiation later. Stronger fund-level credibility when LPs ask how value creation translates into exits.

Proof

The market is already telling sponsors where execution stories break.

52%

of PE leaders say the quality of portco leadership causes tension and misalignment with management teams. Execution risk is often visible before exit, but rarely formally pressure-tested.

Source: AlixPartners Tenth Annual PE Leadership Survey, 2025.

76%

of senior operating partners cited balancing deal-team and management-team needs as a core part of success. Execution Underwriting helps translate the thesis across that triangle.

Source: Blue Ridge Partners, The Legends of Value Creation, 2025.

$3.8T

in unrealized PE value across approximately 32,000 unsold companies. Exit pressure is increasing, not decreasing. The value bridge must be demonstrably executable, not only strategically compelling.

Source: Bain Global Private Equity Report, 2026.

Who runs this

Operator experience, not advisory distance.

Mike Litvak

Founder, Forged Horizons Advisors

Five P&L and practice launches at Gartner and UMS Group. Six years at IBM Corporate Development in a buyer-side deal sourcing role — pattern recognition from 100+ C-suite management meetings, 20+ years as strategy and operational consultant. Operating roles at Gartner and American Express. Prior: Gartner Consulting, Arthur D. Little, UMS GROUP. NYU Stern MBA + Cornell ILR degrees

IBM Corporate Development Kyndryl Spinout Analysis Gartner Practice Builder 100+ C-Suite Management Meetings

Where is one company already behind the thesis, but not yet behind the dashboard?

In 20 minutes, we identify the likely gap, where it may surface, and whether a deeper Execution Underwriting diagnostic is worth your time.